JapanStake
Wholesale Trade · Fiscal year end Mar 31

VITAL KSK HOLDINGS,INC.

3151

株式会社バイタルケーエスケー・ホールディングス

FIGI BBG000BXRNB23151.T3151 JPCorp. no. 4010901024332

Latest half-year results

First half · fiscal year to 2026-03 · filed 2025-11-14

For the first half of the fiscal year to 2026-03: Revenue ¥300.2 billion (+1.1% YoY), Ordinary income ¥5 billion (+38.6% YoY), Net income ¥5 billion (+105.3% YoY).

This periodYear on year
Revenue¥300.2bn+1.1%
Ordinary profit¥5.0bn+38.6%
Net profit to owners¥5.0bn+105.3%

From the securities report on EDINET, which states no forecast. History via /v1/companies/3151/earnings-releases.

Financials

Japan GAAP · consolidated · fiscal year to 2026-03-31
Revenue
¥610.5bn
Net income
¥7.4bn
ROE
6.6%
Equity ratio
36.6%
Dividend / share
¥70
Employees
3,871
Revenue · ¥bn
FY2022: ¥578.8bn 579 FY2022FY2023: ¥581.3bn 581 FY2023FY2024: ¥587.5bn 587 FY2024FY2025: ¥600.4bn 600 FY2025FY2026: ¥610.5bn 610 FY2026
Net income · ¥bn
FY2022: ¥4.8bn 4.77 FY2022FY2023: ¥4.8bn 4.83 FY2023FY2024: ¥5.8bn 5.84 FY2024FY2025: ¥7.3bn 7.31 FY2025FY2026: ¥7.4bn 7.36 FY2026
Fiscal yearRevenueNet incomeTotal assetsNet assetsROEEPSOperating CF
2026-03-31¥610.5bn¥7.4bn¥320.6bn¥118.7bn6.6%¥152.29¥4.8bn
2025-03-31¥600.4bn¥7.3bn¥299.4bn¥107.3bn6.9%¥149.02−¥8.0bn
2024-03-31¥587.5bn¥5.8bn¥317.3bn¥105.9bn5.7%¥115.03¥23.6bn
2023-03-31¥581.3bn¥4.8bn¥297.3bn¥100.2bn4.9%¥92.69−¥3.0bn
2022-03-31¥578.8bn¥4.8bn¥313.0bn¥100.0bn4.7%¥87.88¥7.5bn

Indicators

Computed by us from filings · fiscal year to 2026-03-31
MetricValuePercentile among listed companies
ROE, %6.636.2
Ordinary margin0.012813.5
Equity ratio, %36.622.3
Revenue growth0.016932.6
Net income growth0.007436.4
Operating cash flow / assets0.015121.6
Policy-uncertainty measure0.00 Share of the report's text discussing policy-related uncertainty, by policy area. Proprietary text method.
Ownership activity 0 filer(s) stated they may make proposals in 365 days; 0 new 5% holder(s) in 180 days; net stake change 0.00pt in 90 days; 6.6% held by other listed companies.

Results wording balance: +0.67. Proprietary text method; it describes the wording only and does not interpret context.

Interest example: if all ¥5.8bn of reported debt repriced by 50 basis points, a year's interest would rise by ¥29m, 0.6% of operating cash flow. Our arithmetic only, not a forecast: fixed-rate debt and hedges are ignored.

Via /v1/companies/3151/indicators. Descriptive figures, not a rating and not investment advice.

From other filings

As the company states them
Share buyback, report to —: acquired amount not stated of a ¥4.0bn limit. /v1/companies/3151/buybacks
Internal control, 2026-06-19: see filing 上記の評価の結果、当事業年度末日時点において、当社の財務報告に係る内部統制は有効であると判断しております。 Filing

Segments, votes and tender offers

Stated in EDINET filings
Segments: Medicine Wholesale, Pharmacy Business, Veterinary Drugs Wholesale Business, Pharmaceutical Business, Nursing Care Related Rental and Other Business. /v1/companies/3151/segments
Latest voting result: 2026-06-25 · 取締役(監査等委員である取締役を除く。)9名選任の件 · passed. /v1/companies/3151/voting

Ownership changes

All companies →
  • 2025-02-28
    Below 5%−9.42pt

    individual filer cut holdings in VITAL KSK HOLDINGS,INC. (3151) to 2.64% from 12.06%, below the 5% threshold.

    01020304050
    S100V9TFOriginal filing (PDF, Japanese)
  • 2025-02-28
    Threshold

    Holdings of individual filer in VITAL KSK HOLDINGS,INC. (3151) moved below 10% (12.06% -> 2.64%).

    01020304050
    S100V9TFOriginal filing (PDF, Japanese)
  • 2025-02-28
    New 5% stake

    MH LLC disclosed a 9.76% stake in VITAL KSK HOLDINGS,INC. (3151), crossing the 5% reporting threshold.

    01020304050
    S100V9Y3Filer profileOriginal filing (PDF, Japanese)
  • 2024-02-06
    Amendment+1.87pt

    individual filer filed a correction to a 5% report on VITAL KSK HOLDINGS,INC. (3151).

    S100SQYOOriginal filing (PDF, Japanese)
  • 2024-02-02
    Increase+1.87pt

    individual filer raised holdings in VITAL KSK HOLDINGS,INC. (3151) to 12.06% from 10.19%.

    01020304050
    S100SPUKOriginal filing (PDF, Japanese)

Trades by 5% holders

From the 60-day trade tables in 5% reports
HolderPeriodNet sharesNet % of sharesAvg. filed priceRange
individual filer2025-02-20 – 2025-02-20-4,892,500−9.43pt——
合同会社MH2025-02-20 – 2025-02-20+4,892,500+9.43pt¥1,152¥1,152–1,152

Net shares and the average are our calculations. Prices are filed prices as stated by the filer, mostly for off-market trades; they are not market prices. Stock lending, custody transfers and option exercises are excluded from net shares. Every row via /v1/companies/3151/trades.

5% filings

Large shareholding reports on 3151
FiledFilerStakeChangeStated purpose
2025-03-07MH LLC9.76%——
2025-03-07MH LLC9.76%——
2025-02-28individual filer2.64%−9.42pt—
2025-02-28MH LLC9.76%——
2024-02-06individual filer12.06%+1.87pt—
2024-02-02individual filer12.06%+1.87pt—

Cross-shareholdings

From the annual report's status of shareholdings
Listed strategic holdings
— issues
Book value
—
Sold in the year
— — issues
Bought in the year
— — issues
Mutual, both reports
21
Held by listed cos.
23
HoldsBook valueShares vs. prior yearMutual
Otsuka Holdings Co., Ltd. 4578¥16.1bn0.0%both reports
Otsuka Holdings Co., Ltd. 4578¥13.9bn0.0%both reports
TERUMO CORPORATION 4543¥2.1bn0.0%no
SANTEN PHARMACEUTICAL CO.,LTD. 4536¥1.5bn-10.7%both reports
ONO PHARMACEUTICAL CO., LTD. 4528¥1.3bn0.0%stated
DAIICHI SANKYO COMPANY, LIMITED 4568¥1.1bn0.0%both reports
Eisai Co., Ltd. 4523¥1.0bn0.0%both reports
Astellas Pharma Inc. 4503¥1.0bn0.0%no
ONO PHARMACEUTICAL CO., LTD. 4528¥1.0bn-33.2%stated
CHUGAI PHARMACEUTICAL CO., LTD. 4519¥0.9bn0.0%no

Held by: DAIICHI SANKYO COMPANY, LIMITED 4568, Shionogi & Co.,Ltd. 4507, The 77Bank,Ltd. 8341, TSUMUGU Holdings, Inc. 3055, Otsuka Holdings Co., Ltd. 4578, KISSEI PHARMACEUTICAL CO.,LTD. 4547, SANTEN PHARMACEUTICAL CO.,LTD. 4536, KAMEI CORPORATION 8037, ZERIA PHARMCEUTICAL CO., LTD. 4559, Mochida Pharmaceutical Co.,Ltd. 4534, ASKA Pharmaceutical Holdings CO., Ltd. 4886, Nippon Shinyaku Co.,Ltd. 4516 and 12 more

Purposes, all holdings and mutual flags via /v1/companies/3151/cross-holdings. Share changes include stock splits.

Major shareholders

As of fiscal year end 2026-03-31
ShareholderSharesRatio
合同会社MH4,892,00010.09%
日本マスタートラスト信託銀行㈱(信託口)3,840,0007.92%
STATE STREET BANK AND TRUST COMPANY 5051031,414,0002.91%
individual holder1,384,0002.85%
ケーエスケー従業員持株会1,276,0002.63%
㈱日本カストディ銀行(信託口)1,223,0002.52%
individual holder1,187,0002.44%
individual holder1,029,0002.12%
みずほ信託銀行㈱退職給付信託1,014,0002.09%
バイタルネット従業員持株会958,0001.97%

U.S. funds holding 3151

SEC Form N-PORT, reports to 2026-07-31

41 U.S. funds held 2,531,839 shares worth $26.0m.

FundSharesValue% of fundAs of
VANGUARD TOTAL INTERNATIONAL STOCK INDEX FUND
VANGUARD STAR FUNDS
463,647$4.9m0.001%2026-07-31
VANGUARD DEVELOPED MARKETS INDEX FUND
VANGUARD TAX-MANAGED FUNDS
358,615$3.4m0.001%2026-06-30
THE JAPANESE SMALL COMPANY SERIES
DFA INVESTMENT TRUST CO
218,100$2.3m0.057%2026-07-31
INTERNATIONAL CORE EQUITY 2 PORTFOLIO
DFA INVESTMENT DIMENSIONS GROUP INC
196,385$2.1m0.005%2026-07-31
Dimensional International Small Cap Value ETF
Dimensional ETF Trust
188,400$2.0m0.040%2026-07-31

Up to 25 funds per stock via the API.

Get this as JSON

GET /v1/companies/3151
GET /v1/companies/3151/financials
GET /v1/companies/3151/details
GET /v1/companies/3151/segments
GET /v1/companies/3151/voting
GET /v1/companies/3151/tender-offers
GET /v1/companies/3151/indicators
GET /v1/companies/3151/earnings-releases
GET /v1/events?ticker=3151
GET /v1/companies/3151/trades         
GET /v1/companies/3151/cross-holdings 
GET /v1/companies/3151/brief

Plans from $9 a month · Documentation